Patents expiring in 2030

US 7795495

Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them

The Regents of the University of California · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7794998

Primate T-lymphotropic viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7795302

Use of compositions for treating rosacea

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2754902

COMPOSES D'ACIDE GRAS ESSENTIEL

AMARIN NEUROSCIENCE LTD [GB] · Granted Thu Sep 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799822

Phenyl sulfonamides as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799777

Salts of potassium ATP channel openers and uses thereof

ESSENTIALIS, INC. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799798

Spiroheterocyclic compounds and their uses as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799789

Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799070

Coated implantable medical device

Cook Regentec LLC · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799533

Polypeptides, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799762

Acyl pseudodipeptides which carry a functionalised auxialiary arm

OM PHARMA · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799329

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799518

Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

The Board of Regents of the University of Texas System · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7799753

Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents

State of Rhode Island and Providence Plantations · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2229943

Verbindungen zur Behandlung der peripheren Neuropathie

BIOCODEX [FR] · Granted Wed Sep 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Sep 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803558

Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803614

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803380

Compositions and methods for diagnosis and treatment of tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803940

Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases

Takeda Pharmaceutical Company Limited · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803822

Triazole derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803812

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803913

Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803764

Amphipathic glycopeptides

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803560

Methods of screening for antagonists of mammalian monocyte chemoattractant protein receptors

The Regents of the University of California · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803385

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803939

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803149

Coated medical device

Cook Regentec LLC · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7802988

Method for whitening teeth

DISCUS DENTAL, LLC · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803386

Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7803363

Attenuated Francisella bacteria

The Board of Regents of the University of Texas System · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2010247626

PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION

ALBRECHT VOLKER [DE] · Granted Thu Sep 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807805

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807787

NELL-1 peptide

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807689

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807640

Orally administered peptides synergize statin activity

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807645

Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807463

Pre-transplant accommodated organs resistant to anti-donor immunity

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807623

Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807619

Compositions and methods for modification of biomolecules

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807618

Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues

The Board of Regents of the University of Texas System · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807179

Modified reoviral therapy

The Board of Regents of the University of Texas System · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807168

Selection of human TNFα specific antibodies

VACCINEX, INC. · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807644

Chimeric proteins with phosphatidylserine binding domains

The Board of Regents of the University of Oklahoma · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807781

Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

The Regents of the University of Colorado · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807458

Multilineage-inducible cells and uses thereof

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807164

Lyophilized VEGF antagonist formulations for intravitreal administration

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807651

Methods and materials for pain management

The Board of Regents of the University of Texas System · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807393

Biomarkers for prostate cancer

Northwestern University · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)